Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

Author:

Zhou Junwen,Wu Runguo,Williams Claire,Emberson Jonathan,Reith Christina,Keech Anthony,Robson John,Wilkinson Kenneth,Armitage Jane,Gray Alastair,Simes John,Baigent Colin,Mihaylova BorislavaORCID

Abstract

Abstract Objectives The aim of this study was to develop prediction models for the individual-level impacts of cardiovascular events on UK healthcare costs. Methods In the UK Biobank, people 40–70 years old, recruited in 2006–2010, were followed in linked primary (N = 192,983 individuals) and hospital care (N = 501,807 individuals) datasets. Regression models of annual primary and annual hospital care costs (2020 UK£) associated with individual characteristics and experiences of myocardial infarction (MI), stroke, coronary revascularization, incident diabetes mellitus and cancer, and vascular and nonvascular death are reported. Results For both people without and with previous cardiovascular disease (CVD), primary care costs were modelled using one-part generalised linear models (GLMs) with identity link and Poisson distribution, and hospital costs with two-part models (part 1: logistic regression models the probability of incurring costs; part 2: GLM with identity link and Poisson distribution models the costs conditional on incurring any). In people without previous CVD, mean annual primary and hospital care costs were £360 and £514, respectively. The excess primary care costs were £190 and £360 following MI and stroke, respectively, whereas excess hospital costs decreased from £4340 and £5590, respectively, in the year of these events, to £190 and £410 two years later. People with previous CVD had more than twice higher annual costs, and incurred higher excess costs for cardiovascular events. Other characteristics associated with higher costs included older age, female sex, south Asian ethnicity, higher socioeconomic deprivation, smoking, lower level of physical activities, unhealthy body mass index, and comorbidities. Conclusions These individual-level healthcare cost prediction models could inform assessments of the value of health technologies and policies to reduce cardiovascular and other disease risks and healthcare costs. An accompanying Excel calculator is available to facilitate the use of the models.

Funder

Health Technology Assessment Programme

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference26 articles.

1. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update From the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.

2. British Heart Foundation. UK Factsheet. Heart and Circulatory Diseases (Cardiovascular Disease; CVD). 2022. https://www.bhf.org.uk/what-we-do/our-research/heart-statistics. Accessed 1 May 2022.

3. Wilkins E, Wilson L, Wickramasinghe K, et al. European Cardiovascular Disease Statistics 2017. 2017. https://ehnheart.org/cvd-statistics/cvd-statistics-2017.html. Accessed 1 May 2022.

4. OECD. Total healthcare expenditure in the United Kingdom from 2000 to 2020 (In billion GBP). 2021. https://www.statista.com/statistics/317669/healthcare-expenditure-in-the-united-kingdom/. Accessed 1 May 2022.

5. Danese MD, Gleeson M, Kutikova L, et al. Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. 2016;6(8): e011805.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3